Transcriptional Profiling of Peripheral Blood in Pancreatic Adenocarcinoma Patients Identifies Diagnostic Biomarkers
Authors:
- Octavio CabaOCOctavio Caba
- Jose PradosJPJose Prados
- Raúl OrtizRORaúl Ortiz
- Cristina Jiménez-LunaCJCristina Jiménez-Luna
- Consolación MelguizoCMConsolación Melguizo
- Pablo J. ÁlvarezPÁPablo J. Álvarez
- Juan R. DelgadoJDJuan R. Delgado
- Antonio IrigoyenAIAntonio Irigoyen
- Ignacio RojasIgnacio Rojas
- Javier Pérez-FloridoJPJavier Pérez-Florido
- Carolina TorresCTCarolina Torres
- Sonia PeralesSPSonia Perales
- 29 July 2014
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 59 (11) , 2714-2720
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy associated with poor survival rates. Fast detection of PDAC appears to be the most relevant strategy to improve the long-term survival of patients. Our objective was to identify new markers in peripheral blood that differentiates between PDAC patients and healthy controls. Peripheral blood samples from PDAC patients (n = 18) and controls (n = 18) were analyzed by whole genome cDNA microarray hybridization. The most relevant genes were validated by quantitative real-time PCR (RT-qPCR) in the same set of samples. Finally, our gene prediction set was tested in a blinded set of new peripheral blood samples (n = 30). Microarray studies identified 87 genes differentially expressed in peripheral blood samples from PDAC patients. Four of these genes were selected for analysis by RT-qPCR, which confirmed the previously observed changes. In our blinded validation study, the combination of CLEC4D and IRAK3 predicted the diagnosis of PDAC with 93 % accuracy, with a sensitivity of 86 % and specificity of 100 %. Peripheral blood gene expression profiling is an useful tool for the diagnosis of PDAC. We present a validated four-gene predictor set (ANKRD22, CLEC4D, VNN1, and IRAK3) that may be useful in PDAC diagnosis.Keywords
This publication has 36 references indexed in Scilit:
- Current status of molecular markers for early detection of sporadic pancreatic cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2011
- A case-controlled validation study of a blood-based seven-gene biomarker panel for colorectal cancer in MalaysiaJournal of Experimental & Clinical Cancer Research, 2010
- A framework for oligonucleotide microarray preprocessingBioinformatics, 2010
- Gene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients with Non–Small Cell Lung Cancer from Patients with Nonmalignant Lung DiseaseCancer Research, 2009
- A blood‐based biomarker panel for stratifying current risk for colorectal cancerInternational Journal of Cancer, 2009
- Use of Gene Expression Profiles in Cells of Peripheral Blood to Identify New Molecular Markers of Acute PancreatitisArchives of Surgery, 2008
- New Markers of Pancreatic Cancer Identified Through Differential Gene Expression Analyses: Claudin 18 and Annexin A8American Journal of Surgical Pathology, 2008
- Analysis of mortality rates for pancreatic cancer across the worldHPB, 2008
- Loss of the innate immunity negative regulator IRAK-M leads to enhanced host immune defense against tumor growthMolecular Immunology, 2007
- Sepsis-induced suppression of lung innate immunity is mediated by IRAK-MJournal of Clinical Investigation, 2006